CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD.

China National Accord Medicines Corporation Ltd.

000028

CNE0000009N6

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 26/06/2024 am IST			5-day change	1st Jan Change
33.11 ^CNY	+1.91%		-3.89%	+14.21%

19/06	China National Accord Medicines Corporation Ltd. Announces Final Cash Dividend on B Shares for the Year 2023, Payable on 27 June 2024	CI
19/06	China National Accord Medicines Corporation Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 25 June 2024	CI

China National Accord Medicines Corporation Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 25 June 2024

June 20, 2024 at 01:02 am IST

China National Accord Medicines Corporation Ltd. announced final cash dividend of CNY 6.80 per 10 shares on A shares (tax included) for the year 2023. Record date: 24 June 2024, Ex-date: 25 June 2024 and Payment date: 25 June 2024.

Latest news about China National Accord Medicines Corporation Ltd.

China National Accord Medicines Corporation Ltd. Announces Final Cash Dividend on B Shares for the Year 2023, Payable on 27 June 2024	20/06	CI
China National Accord Medicines Corporation Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 25 June 2024	20/06	CI
China National Accord Medicines Corporation Ltd. Approves Cash Dividend for the Year 2023	09/05	CI
China National Accord Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
China National Accord Medicines Corporation Ltd. Proposes Final Cash Dividend for the Year 2023	09/04	CI
China National Accord Medicines Corporation Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	07/04	CI
China National Accord Medicines' Profit Slides 4% in Q3	26/23/26	MT
China National Accord Medicines Corporation Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/23/26	CI
China National Accord Medicines Corporation Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/23/28	CI
Correction: Sinopharm Subsidiary Sinopharm Accord Logs Over 29% Jump in H1 Net Profit	08/23/08	MT
Sinopharm Group Logs Over 29% Jump in H1 Net Profit	08/23/08	MT
China National Accord Medicines Approves Final Cash Dividend for 2022	13/23/13	CI
Energy International Investments to Raise HK$150 Million from Share Issue to Affiliate	01/23/01	MT
Sinopharm Accord Logs 44% Rise in Q1 Profit	25/23/25	MT
Sinopharm Accord's Q1 Profit Surges 43.5%	17/23/17	MT
China National Accord Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	17/23/17	CI
China National Accord Medicines Corporation Ltd. Proposes Final Cash Dividend for the Year 2022	14/23/14	CI
Pfizer signs strategic cooperation pact with China's Sinopharm	13/23/13	RE
Sinopharm Accord's 2022 Attributable Profit Up 11%; Shares Jump 5%	13/23/13	MT
China National Accord Medicines Corporation Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	15/23/15	CI
China National Accord Medicines Corporation Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	15/23/15	CI
Merck's COVID treatment expected to launch in China on Friday	11/23/11	RE
China National Accord Medicines Corporation Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	24/22/24	CI
China National Accord Medicines Corporation Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	19/22/19	CI
China National Accord Medicines Corporation Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on June 17, 2022	14/22/14	CI

Chart China National Accord Medicines Corporation Ltd.

Duration

Period

Chart China National Accord Medicines Corporation Ltd.

More charts

Company Profile

China National Accord Medicines Corporation Ltd. is a China-based company principally engaged in the pharmaceutical wholesaling, retailing and manufacturing businesses. The Company's main products include antibiotic preparations, power injections, antibiotic Active Pharmaceutical Ingredients (APIs), respiratory system drugs and cardiovascular and cerebrovascular system drugs, among others. The Company is also involved in the provision of logistics and storage services, leasing services and training services, among others. The Company distributes its products mainly in domestic market.

Sector

Pharmaceuticals

Calendar

05/07/2024 - Extraordinary Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for China National Accord Medicines Corporation Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

33.11 CNY

Average target price

39.17 CNY

Spread / Average Target

+18.31%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD.	+14.21%	2.3B
MCKESSON CORPORATION	+29.50%	78.4B
CARDINAL HEALTH, INC.	+0.30%	25.12B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+14.70%	8.62B
SINOPHARM GROUP CO. LTD.	+1.22%	8.55B
HUADONG MEDICINE CO., LTD	-28.87%	6.91B
H. LUNDBECK A/S	+16.06%	5.34B
GALENICA AG	+1.58%	4.17B
EBOS GROUP LIMITED	-8.90%	3.82B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	-7.62%	3.37B

Pharmaceuticals Wholesale